Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFRGS |
Texto Completo: | http://hdl.handle.net/10183/196922 |
Resumo: | Investigation of hyperferritinemia in metabolic syndrome patients represents a diagnostic challenge, but it is essential for the identification of individuals with iron overload. Hepcidin negatively regulates iron absorption and release. An increase in hepcidin occurs when iron levels are sufficient or in inflammatory states, conditions often associated with hyperferritinemia. Hemochromatosis causes hyperferritinemia due to iron overload, but frequently has low hepcidin levels. Our aim was to evaluate biochemical and molecular parameters related to iron metabolism in patients with metabolic syndrome. We evaluated 94 patients with metabolic syndrome according to the International Diabetes Federation criteria in a cross-sectional study. Anthropometric data and diagnostic criteria for metabolic syndrome, iron dosage, ferritin, transferrin saturation, hepcidin, and the C282Y and H63D mutations in the HFE hemochromatosis gene were evaluated. Prevalence of hyperferritinemia in the study population was 27.7% and was higher in males (46.2%) than in females (14.5%). Increase in transferrin saturation correlated with mutations in the hemochromatosis gene. Hyperferritinemia was associated to transferrin saturation and hepcidin after logistic regression analysis. In conclusion, hyperferritinemia is a frequent finding in metabolic syndrome patients, most frequently in men; and hepcidin assessment can be useful for the investigation of ferritin increase in those subjects. |
id |
UFRGS-2_b8674916684c54e747fef5bee7251a93 |
---|---|
oai_identifier_str |
oai:www.lume.ufrgs.br:10183/196922 |
network_acronym_str |
UFRGS-2 |
network_name_str |
Repositório Institucional da UFRGS |
repository_id_str |
|
spelling |
Rauber, Mariana ReisPilger, Diogo AndreCecconello, Daiane KellerFalcetta, Frederico SoaresMarcondes, Natália AydosFaulhaber, Gustavo Adolpho Moreira2019-07-13T02:36:12Z20190001-3765http://hdl.handle.net/10183/196922001095663Investigation of hyperferritinemia in metabolic syndrome patients represents a diagnostic challenge, but it is essential for the identification of individuals with iron overload. Hepcidin negatively regulates iron absorption and release. An increase in hepcidin occurs when iron levels are sufficient or in inflammatory states, conditions often associated with hyperferritinemia. Hemochromatosis causes hyperferritinemia due to iron overload, but frequently has low hepcidin levels. Our aim was to evaluate biochemical and molecular parameters related to iron metabolism in patients with metabolic syndrome. We evaluated 94 patients with metabolic syndrome according to the International Diabetes Federation criteria in a cross-sectional study. Anthropometric data and diagnostic criteria for metabolic syndrome, iron dosage, ferritin, transferrin saturation, hepcidin, and the C282Y and H63D mutations in the HFE hemochromatosis gene were evaluated. Prevalence of hyperferritinemia in the study population was 27.7% and was higher in males (46.2%) than in females (14.5%). Increase in transferrin saturation correlated with mutations in the hemochromatosis gene. Hyperferritinemia was associated to transferrin saturation and hepcidin after logistic regression analysis. In conclusion, hyperferritinemia is a frequent finding in metabolic syndrome patients, most frequently in men; and hepcidin assessment can be useful for the investigation of ferritin increase in those subjects.application/pdfengAnais da Academia Brasileira de Ciências. Rio de Janeiro, RJ. Vol. 91, n. 2 (2019), artigo e20180286HepcidinasSíndrome metabólicaFerritinasDiagnostic screeningFerritinHepcidinIronMetabolic syndromeHepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndromeinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/otherinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001095663.pdf.txt001095663.pdf.txtExtracted Texttext/plain22656http://www.lume.ufrgs.br/bitstream/10183/196922/2/001095663.pdf.txt10096c6acf579b7ca4ea7909eeeef1a0MD52ORIGINAL001095663.pdfTexto completo (inglês)application/pdf835978http://www.lume.ufrgs.br/bitstream/10183/196922/1/001095663.pdf77443eeda50ebb6efd874277bc7e839fMD5110183/1969222019-07-14 02:37:09.858572oai:www.lume.ufrgs.br:10183/196922Repositório InstitucionalPUBhttps://lume.ufrgs.br/oai/requestlume@ufrgs.bropendoar:2019-07-14T05:37:09Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.pt_BR.fl_str_mv |
Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome |
title |
Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome |
spellingShingle |
Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome Rauber, Mariana Reis Hepcidinas Síndrome metabólica Ferritinas Diagnostic screening Ferritin Hepcidin Iron Metabolic syndrome |
title_short |
Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome |
title_full |
Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome |
title_fullStr |
Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome |
title_full_unstemmed |
Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome |
title_sort |
Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome |
author |
Rauber, Mariana Reis |
author_facet |
Rauber, Mariana Reis Pilger, Diogo Andre Cecconello, Daiane Keller Falcetta, Frederico Soares Marcondes, Natália Aydos Faulhaber, Gustavo Adolpho Moreira |
author_role |
author |
author2 |
Pilger, Diogo Andre Cecconello, Daiane Keller Falcetta, Frederico Soares Marcondes, Natália Aydos Faulhaber, Gustavo Adolpho Moreira |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Rauber, Mariana Reis Pilger, Diogo Andre Cecconello, Daiane Keller Falcetta, Frederico Soares Marcondes, Natália Aydos Faulhaber, Gustavo Adolpho Moreira |
dc.subject.por.fl_str_mv |
Hepcidinas Síndrome metabólica Ferritinas |
topic |
Hepcidinas Síndrome metabólica Ferritinas Diagnostic screening Ferritin Hepcidin Iron Metabolic syndrome |
dc.subject.eng.fl_str_mv |
Diagnostic screening Ferritin Hepcidin Iron Metabolic syndrome |
description |
Investigation of hyperferritinemia in metabolic syndrome patients represents a diagnostic challenge, but it is essential for the identification of individuals with iron overload. Hepcidin negatively regulates iron absorption and release. An increase in hepcidin occurs when iron levels are sufficient or in inflammatory states, conditions often associated with hyperferritinemia. Hemochromatosis causes hyperferritinemia due to iron overload, but frequently has low hepcidin levels. Our aim was to evaluate biochemical and molecular parameters related to iron metabolism in patients with metabolic syndrome. We evaluated 94 patients with metabolic syndrome according to the International Diabetes Federation criteria in a cross-sectional study. Anthropometric data and diagnostic criteria for metabolic syndrome, iron dosage, ferritin, transferrin saturation, hepcidin, and the C282Y and H63D mutations in the HFE hemochromatosis gene were evaluated. Prevalence of hyperferritinemia in the study population was 27.7% and was higher in males (46.2%) than in females (14.5%). Increase in transferrin saturation correlated with mutations in the hemochromatosis gene. Hyperferritinemia was associated to transferrin saturation and hepcidin after logistic regression analysis. In conclusion, hyperferritinemia is a frequent finding in metabolic syndrome patients, most frequently in men; and hepcidin assessment can be useful for the investigation of ferritin increase in those subjects. |
publishDate |
2019 |
dc.date.accessioned.fl_str_mv |
2019-07-13T02:36:12Z |
dc.date.issued.fl_str_mv |
2019 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/other |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10183/196922 |
dc.identifier.issn.pt_BR.fl_str_mv |
0001-3765 |
dc.identifier.nrb.pt_BR.fl_str_mv |
001095663 |
identifier_str_mv |
0001-3765 001095663 |
url |
http://hdl.handle.net/10183/196922 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.pt_BR.fl_str_mv |
Anais da Academia Brasileira de Ciências. Rio de Janeiro, RJ. Vol. 91, n. 2 (2019), artigo e20180286 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFRGS instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Repositório Institucional da UFRGS |
collection |
Repositório Institucional da UFRGS |
bitstream.url.fl_str_mv |
http://www.lume.ufrgs.br/bitstream/10183/196922/2/001095663.pdf.txt http://www.lume.ufrgs.br/bitstream/10183/196922/1/001095663.pdf |
bitstream.checksum.fl_str_mv |
10096c6acf579b7ca4ea7909eeeef1a0 77443eeda50ebb6efd874277bc7e839f |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
lume@ufrgs.br |
_version_ |
1817725050636206080 |